Benzinga's Top Pre-Market Losers
Clovis Oncology (NASDAQ: CLVS) shares fell 47.28% to $11.33 in the pre-market trading. Clovis Oncology reported negative outcome of CO-101 in pivotal LEAP pancreatic cancer study.
Star Scientific (NASDAQ: STSI) shares dropped 10.94% to $2.28 in pre-market trading. Star Scientific reported its Q3 net profit of $0.4 million, versus a year-ago net loss of $6.6 million.
J. C. Penney Company (NYSE: JCP) dipped 2.66% to $20.09 in the pre-market session. J. C. Penney reported Q3 loss.
Randgold Resources Limited (NASDAQ: GOLD) dipped 1.25% to $110.94 in the pre-market session. Randgold Resources' PEG ratio is -6.39.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.